DSMF.F Stock Overview
DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 1/6 |
DSM-Firmenich AG Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €105.04 |
52 Week High | €105.04 |
52 Week Low | €101.00 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | 4.00% |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -2.08% |
Recent News & Updates
Recent updates
Shareholder Returns
DSMF.F | US Chemicals | US Market | |
---|---|---|---|
7D | 0% | 2.3% | 3.3% |
1Y | n/a | 11.2% | 25.0% |
Return vs Industry: Insufficient data to determine how DSMF.F performed against the US Chemicals industry.
Return vs Market: Insufficient data to determine how DSMF.F performed against the US Market.
Price Volatility
DSMF.F volatility | |
---|---|
DSMF.F Average Weekly Movement | n/a |
Chemicals Industry Average Movement | 5.9% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.5% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: DSMF.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine DSMF.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1902 | 28,685 | Dimitri de Vreeze | www.dsm-firmenich.com |
DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. It operates through Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients.
DSM-Firmenich AG Fundamentals Summary
DSMF.F fundamental statistics | |
---|---|
Market cap | US$30.60b |
Earnings (TTM) | -US$707.07m |
Revenue (TTM) | US$11.42b |
2.7x
P/S Ratio-43.3x
P/E RatioIs DSMF.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
DSMF.F income statement (TTM) | |
---|---|
Revenue | €10.63b |
Cost of Revenue | €8.02b |
Gross Profit | €2.61b |
Other Expenses | €3.27b |
Earnings | -€658.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Jul 30, 2024
Earnings per share (EPS) | -2.48 |
Gross Margin | 24.57% |
Net Profit Margin | -6.19% |
Debt/Equity Ratio | 19.2% |
How did DSMF.F perform over the long term?
See historical performance and comparison